Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Norberto J. DeSousa"'
Autor:
Norberto J. DeSousa, Cassandra L. Uchida, Floyd R. Sallee, Paul Hammerness, Jeffrey H. Newcorn, Bev Incledon, Timothy E. Wilens, Stephen V. Faraone, Steven R. Pliszka
Publikováno v:
Journal of Attention Disorders
Objective: The Before School Functioning Questionnaire and Parent Rating of Evening and Morning Behavior–Revised assess early morning (BSFQ, PREMB-R AM subscale) and late afternoon/evening (PREMB-R PM subscale) functional impairment in children wit
Autor:
Stephen V. Faraone, Norberto J. DeSousa, Tayyaba F Khan, Stephanie Rhoten, Frank A. Lopez, Helen Doll, Bev Incledon, Hannah Lewis, Floyd R. Sallee, Jeffrey H. Newcorn
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: Inadequately controlled symptoms and associated impaired functioning have a significant negative impact on caregivers of children with attention-deficit/hyperactivity disorder (ADHD). This study aimed to assess the impact of evening-dosed
Publikováno v:
Clinical Therapeutics. 42:2332-2340
Purpose HLD200 is the first evening-dosed, delayed-release and extended-release methylphenidate (DR/ER-MPH) designed to delay initial release of MPH and provide treatment effects throughout the day and into the evening for individuals with attention-
Autor:
Floyd R. Sallee, Mary Ann McDonnell, Andrea Marraffino, Norberto J. DeSousa, Bev Incledon, Sharon B. Wigal, Matthew Brams, John M. Turnbow, Ann C. Childress, Andrew J. Cutler
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: HLD200, a once-daily, evening-dosed, delayed-release and extended-release methylphenidate (DR/ER-MPH), was designed to provide therapeutic effect beginning upon awakening and lasting into the evening. This pivotal, randomized, double-blin
Autor:
Lewis E. Warrington, Norberto J. DeSousa, Andrew J. Cutler, Floyd R. Sallee, Michelle D. Po, Ann C. Childress, Bev Incledon
Publikováno v:
The Journal of clinical psychiatry. 82(4)
Objective: Delayed-release and extended-release methylphenidate (DR/ER-MPH), the first stimulant predicted to be absorbed primarily in the colon, demonstrated significant improvements in attention-deficit/hyperactivity disorder (ADHD) symptoms and fu
Autor:
Stephen V. Faraone, Marina Komolova, Norberto J. DeSousa, Timothy E. Wilens, F. Randy Sallee, Bev Incledon
Publikováno v:
The Journal of Clinical Psychiatry. 81
OBJECTIVE Children with attention-deficit/hyperactivity disorder (ADHD) frequently manifest behavioral difficulties in the morning prior to school and in the afternoons and evenings. We sought to establish norms for 2 time-specific measures of functi
Autor:
Bev Incledon, Jogarao V. S. Gobburu, Shailly Mehrotra, Norberto J. DeSousa, Angus McLean, Ann C. Childress
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objective: Current extended-release (ER) formulations of psychostimulants used for treatment of attention-deficit/hyperactivity disorder (ADHD) provide an extended duration of ADHD symptom control; however, the onset of efficacy can be protracted and
Autor:
Steven R. Pliszka, Ann Catherine Childress, Andrew J. Cutler, Andrea Marraffino, Norberto J. DeSousa, Floyd R. Sallee, Bev Incledon
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 59:S155-S156
Autor:
Ann Catherine Childress, Steven R. Pliszka, Andrew J. Cutler, Andrea Marraffino, Norberto J. DeSousa, Floyd R. Sallee, Bev Incledon
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 59:S152-S153
Autor:
Angus McLean, Jogarao V. S. Gobburu, Tao Liu, Michelle D. Po, Bev Incledon, Norberto J. DeSousa, Floyd R. Sallee
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: HLD200, an oral, once-daily, evening-dosed, delayed-release, and extended-release methylphenidate (DR/ER-MPH), was designed to provide efficacy from the early morning, throughout the day, and into the evening to individuals with attention